期刊文献+

流式细胞术检测血小板活化的影响因素分析 被引量:13

Assessment of affecting factors in measuring activating platelets with the method of flow cytometry
下载PDF
导出
摘要 目的:探讨流式细胞术(FCM)检测血小板活化的影响因素。方法:采集6名志愿者静脉血,枸橼酸钠为抗凝剂,室温放置不同时间后进行三色免疫荧光标记,FCM检测血小板早期活化标志物纤维蛋白原受体(Fib-R,即PAC-1)和晚期活化标志物P选择素(CD62P)的变化。结果:血小板活化标志物PAC-1和CD62P随着放置时间的延长而表达增加(P<0.05)。抽血后10min和30minPAC-1和CD62P测定值分别相差2.7%和3.5%。且抽血后在不同的活化水平下重复检测多次,结果重复性好,其变异系数(CV)<5%。结论:在室温,枸橼酸钠抗凝条件下,放置时间对血小板活化标志物PAC-1和CD62P的检测结果有较大影响,宜在30min内对采集血液免疫荧光标记后进行流式细胞仪检测。 AIM : To investigate the affecting factors of detecting platelet activation by flow cytometry (FCM). METHODS: Using decoagulant of natrium citricum, anticoagnlated peripheral venous bloods from 6 healthy donors were labeled with the method of three - colour immunofluorescence assay. Platelet activation markers fibrinogen receptor ( Fib - R, PAC - 1 ) and P - selectin (CD62P) were measured. In the same time, the reproducibility of FCM was assessed. RESULTS: The platelet activation markers PAC -1 and CD62P at each time point showed significant difference(P 〈0.05). The ratio was increased with time extending. The positive ratio of PAC - 1 and CD62P immediately measured ( within 10 min ) was 2. 7% and 3.5% less than those at time point of 30 min. The results were measured several times under different activation levels. The coefficient of variation was less than 5%. CONCLUSION: In room temperature and with decoagulant of natrium citricum, if the measurements of PAC - 1 and CD62P are finished within 30 min after sampling, good reproducibility should be achieved.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2009年第3期510-512,共3页 Chinese Journal of Pathophysiology
基金 广东省科技厅科研基金资助项目(No.53064) 广州市医药卫生科技重点资助项目(No.2004Z006)
关键词 流式细胞术 血小板 血小板糖蛋白GPⅡb-Ⅲa复合物 CD62P Flow cytometry Blood platelets Platelet glycoprotein GPⅡb - Ⅲa complex CD62P
  • 相关文献

参考文献7

二级参考文献19

  • 1王兆--,中华血液学杂志,1996年,17卷,9期,472页 被引量:1
  • 2Jansen FW,Vredevoogd CB.Complications of hysteroscopy:aprospective,multicenter study[J].Obstet Gynecol,2000,96(2):266-270. 被引量:1
  • 3Mueller MR,Salat A,Stangl P,et al.Variable platelet response to low-dose ASA and the risk of limb deterioration in patient submitted to peripheral arterial angioplasty[J].Thromb Haemost,1997,78:1003-1007. 被引量:1
  • 4Miles Dalby,MD,Gilles Montalescot,MD,et al.Results of the Platelet Activity Extinction in Non Q-Wave Myocardial Infarction With Aspirin,Clopidogrel,and Eptifibatide (PEACE)Study.JACC Vol.43,No.2,2004 January 21,2004:162-170. 被引量:1
  • 5Wu G X,Li F G,Li P X,et al.Detection of plasma alpha-granule membrane protein (CD62P) using radio labeled monoclonal antibodies in thrombotic disease[J].Haemostasis,1993,23:121-128. 被引量:1
  • 6Fitzgerald DJ,Louis R.Platelet activation in unstable coronary disease[J].N Eng J Med,1986,315:983. 被引量:1
  • 7Macchi L,Christiaens L,Brabant S,et al.Resistance to aspirin in vitro is associated with increased p latelet sensitivity to adenosine diphosphate[J].Thromb Res,2002,107:45-49. 被引量:1
  • 8Marcus EM,Alex IM,Christopher RB,et al.Aspirin inhibits surface glycoprotein Ⅱb/Ⅲa,P-selection,CD63,and CD107a receptor expression on human platelets[J].Blood Coagulation and Fibrinolvsis,2003,14:249-253. 被引量:1
  • 9Antiplatelet Trialist's Collaboration Collaborative.Over view of random-ized trial of antiplatelet the therapy Ⅲ.Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients.BMJ,1994,308:235 被引量:1
  • 10Antiplatelet Trialist's Collaboration.Collaborative over view of random-ized trial of antiplatelet therapy I:Prevertion of death,myocardial in fraction,and stroke by prolongde antiplatelet therapy in various cate-gories of patients.BM J,1994,308:81 被引量:1

共引文献13

同被引文献148

引证文献13

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部